Literature DB >> 28577411

Tau pathology and cognitive reserve in Alzheimer's disease.

Merle Christine Hoenig1, Gérard Nisal Bischof2, Jochen Hammes3, Jennifer Faber4, Klaus Fliessbach5, Thilo van Eimeren6, Alexander Drzezga7.   

Abstract

Cognitive reserve (CR) is defined as the ability to maintain functionality despite accumulating pathology. Education has been used as a proxy for CR. For example, by using positron emission tomography imaging, higher educated Alzheimer's disease (AD) patients presented increased amyloid β pathology than lower educated patients despite equal symptomatology. Whether similar associations exist for in vivo tau pathology remains elusive. We utilized [18F]AV-1451 positron emission tomography imaging to examine whether high-educated AD patients (n = 12) present more severe tau pathology compared with low-educated patients (n = 12) despite equal clinical severity in regions of interest corresponding to the pathologic disease stages defined by Braak & Braak. We report tau pathology in advanced Braak stages associated with parietal and frontal regions in high-educated AD patients, whereas in low-educated AD patients tau accumulation is still confined to lower Braak stages associated with temporal and cingulate regions. Highly educated AD patients seem to be able to tolerate more tau tangle pathology than lower educated patients with comparable cognitive impairment supporting the cognitive reserve hypothesis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cognitive reserve; Education; Positron emission tomography; Tau pathology; [(18)F]AV-1451

Mesh:

Substances:

Year:  2017        PMID: 28577411     DOI: 10.1016/j.neurobiolaging.2017.05.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

Review 1.  Defining Cognitive Reserve and Implications for Cognitive Aging.

Authors:  Corinne Pettigrew; Anja Soldan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-09       Impact factor: 5.081

2.  History of traumatic brain injury interferes with accurate diagnosis of Alzheimer's dementia: a nation-wide case-control study.

Authors:  Tejus Pradeep; Michael J C Bray; Siddharth Arun; Lisa N Richey; Sahar Jahed; Barry R Bryant; Christian LoBue; Constantine G Lyketsos; Paul Kim; Matthew E Peters
Journal:  Int Rev Psychiatry       Date:  2019-11-11

3.  Level of education mitigates the impact of tau pathology on neuronal function.

Authors:  Merle C Hoenig; Gérard N Bischof; Özgür A Onur; Juraj Kukolja; Frank Jessen; Klaus Fliessbach; Bernd Neumaier; Gereon R Fink; Elke Kalbe; Alexander Drzezga; Thilo van Eimeren
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-10       Impact factor: 9.236

4.  Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.

Authors:  Anne Maass; Samuel N Lockhart; Theresa M Harrison; Rachel K Bell; Taylor Mellinger; Kaitlin Swinnerton; Suzanne L Baker; Gil D Rabinovici; William J Jagust
Journal:  J Neurosci       Date:  2017-11-30       Impact factor: 6.167

5.  Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease.

Authors:  Jacob W Vogel; Niklas Mattsson; Yasser Iturria-Medina; Olof T Strandberg; Michael Schöll; Christian Dansereau; Sylvia Villeneuve; Wiesje M van der Flier; Philip Scheltens; Pierre Bellec; Alan C Evans; Oskar Hansson; Rik Ossenkoppele
Journal:  Hum Brain Mapp       Date:  2018-10-19       Impact factor: 5.038

6.  Left frontal connectivity attenuates the adverse effect of entorhinal tau pathology on memory.

Authors:  Julia Neitzel; Nicolai Franzmeier; Anna Rubinski; Michael Ewers
Journal:  Neurology       Date:  2019-06-24       Impact factor: 9.910

Review 7.  Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies.

Authors:  Eider M Arenaza-Urquijo; Prashanthi Vemuri
Journal:  Neurology       Date:  2018-03-28       Impact factor: 9.910

8.  Indication of retrograde tau spreading along Braak stages and functional connectivity pathways.

Authors:  Joseph Seemiller; Gérard N Bischof; Merle C Hoenig; Masoud Tahmasian; Thilo van Eimeren; Alexander Drzezga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-18       Impact factor: 10.057

9.  Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

Authors:  Thilo van Eimeren; Angelo Antonini; Daniela Berg; Nico Bohnen; Roberto Ceravolo; Alexander Drzezga; Günter U Höglinger; Makoto Higuchi; Stephane Lehericy; Simon Lewis; Oury Monchi; Peter Nestor; Matej Ondrus; Nicola Pavese; María Cecilia Peralta; Paola Piccini; José Ángel Pineda-Pardo; Irena Rektorová; María Rodríguez-Oroz; Axel Rominger; Klaus Seppi; A Jon Stoessl; Alessandro Tessitore; Stephane Thobois; Valtteri Kaasinen; Gregor Wenning; Hartwig R Siebner; Antonio P Strafella; James B Rowe
Journal:  Alzheimers Dement (Amst)       Date:  2019-04-02

Review 10.  Highlighting the Role of Cognitive and Brain Reserve in the Substance use Disorder Field.

Authors:  D Cutuli; D Ladrón de Guevara-Miranda; E Castilla-Ortega; L J Santín; P Sampedro-Piquero
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.